Article
Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
23 Feb 2010
Abstract excerpt
PURPOSE: To identify a melanoma microRNA (miRNA) expression signature that is predictive of outcome and then evaluate its potential to improve risk stratification when added to the standard-of-care staging criteria. EXPERIMENTAL DESIGN: Total RNA was extracted from 59 formalin-fixed paraffin-embedded melanoma metastases and hybridized to miRNA arrays containing 911 probes. We then correlated miRNA expression with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
